["{\n\"step_by_step_thinking\": \"The question is asking about prophylaxis against Pneumocystis jirovecii in patients on chemotherapy. The relevant documents mention that prophylaxis for pneumocystic infection in all patients with less than 200 CD4+ cells/mm3 has become accepted practice, and trimethoprim-sulfamethoxazole is the drug of choice for Pneumocystis prophylaxis. However, aerosolized pentamidine is reserved for patients unable to tolerate trimethoprim-sulfamethoxazole.\",\n\"answer_choice\": \"A\"\n}"]